Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Hepatocellular Carcinoma|September 13, 2023
Immune-Based Combination Therapies for Advanced Hepatocellular CarcinomaRiccardo Carloni, Simone Sabbioni, Alessandro Rizzo, et al.
Future Medicinal Chemistry|August 23, 2022
Advances in novel systemic therapies for advanced hepatocellular carcinomaRiccardo Carloni, Alessandro Rizzo, Antonio Cusmai, et al.
World Journal of Clinical Cases|April 28, 2020
Long-term survival of two patients with recurrent pancreatic acinar cell carcinoma treated with radiofrequency ablation: A case reportMariacristina Di Marco, Riccardo Carloni, Stefania De Lorenzo, et al.
Expert Opinion on Drug Safety|November 25, 2022
Treatment-related adverse events of first-line immunotherapy versus sorafenib for advanced hepatocellular carcinoma: a meta-analysisAlessandro Rizzo, Riccardo Carloni, Angela Dalia Ricci, et al.
Pharmaceuticals (Basel, Switzerland)|August 6, 2021
Hacking Pancreatic Cancer: Present and Future of Personalized MedicineAlessandro Di Federico, Valentina Tateo, Claudia Parisi, et al.
Chemistry of Materials : a Publication of the American Chemical Society|April 17, 2023
Amphiphilic Dendritic Hydrogels with Carbosilane Nanodomains: Preparation and Characterization as Drug Delivery SystemsJudith Recio-Ruiz, Riccardo Carloni, Srivathsan Ranganathan, et al.
Biomolecules|October 2, 2019
Exploring the Interactions of Ruthenium (II) Carbosilane Metallodendrimers and Precursors with Model Cell Membranes through a Dual Spin-Label Spin-Probe Technique Using EPRRiccardo Carloni, Natalia Sanz Del Olmo, Paula Ortega, et al.
European Journal of Medicinal Chemistry|February 25, 2021
Elaborated study of Cu(II) carbosilane metallodendrimers bearing substituted iminopyridine moieties as antitumor agentsRiccardo Carloni, Natalia Sanz Del Olmo, Barbara Canonico, et al.
Cancers|May 28, 2022
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment OutcomesAlessandro Di Federico, Mirta Mosca, Rachele Pagani, et al.
Nanoscale|July 5, 2019
Insight into the antitumor activity of carbosilane Cu(ii)-metallodendrimers through their interaction with biological membrane modelsNatalia Sanz Del Olmo, Riccardo Carloni, Ana M Bajo, et al.
Pageof 3